Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
PFE holding history
Pfizer Inc in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q4 2024 holdings
- Shares (Q4 2024)
- 60,414
- Value
- $1.60M
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 60,414 | $1.60M | 0.1% | −16,211−21.2% | Reduced | Holders |
| Q3 2024 | 76,625 | $2.22M | 0.1% | +50,232+190.3% | Added | Holders |
| Q2 2024 | 26,393 | $738.5K | <0.1% | +26,393 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −45,018−100.0% | Sold out | Holders |
| Q3 2023 | 45,018 | $1.49M | 0.2% | +3,043+7.2% | Added | Holders |
| Q2 2023 | 41,975 | $1.54M | 0.2% | +41,975 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −2,874,544−100.0% | Sold out | Holders |
| Q4 2022 | 2,874,544 | $147.3M | 10.7% | +8,794+0.3% | Added | Holders |
| Q3 2022 | 2,865,750 | $125.4M | 21.5% | −21,580−0.7% | Reduced | Holders |
| Q2 2022 | 2,887,330 | $151.4M | 19.0% | −1,932−0.1% | Reduced | Holders |
| Q1 2022 | 2,889,262 | $149.6M | 14.6% | +498,845+20.9% | Added | Holders |
| Q4 2021 | 2,390,417 | $141.2M | 17.9% | +910,417+61.5% | Added | Holders |
| Q3 2021 | 1,480,000 | $63.7M | 9.0% | +1,480,000 | New | Holders |